Skip to main content

Nuvalent, Inc.

NUVLDelisted Jul 15, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001861560

Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2025 vs. Q2 2025

How the institutions holding Nuvalent, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of NUVL: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders2095196−8
Shares71.9M385.5K72.4M+908.0K (+1.3%)
Value$5.49B$29.4M$6.26B+$806.2M (+14.8%)

5 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Nuvalent, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Sold out (33)

Institutions that held Nuvalent, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (5)

Institutions that held Nuvalent, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NUVL in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Norges Bank374,597$28.6M
E Fund Management Co., Ltd.5,401$412.1K
CIBC World Markets Corp5,295$404.0K
First Horizon Advisors, Inc.154$11.8K
Parkworth Wealth Management, Inc.4$305